Business Context and Reporting Period
This Form 6-K filing by Nano-X Imaging Ltd. (Nanox) covers the month of November 2025. The report discloses a registered direct offering of ordinary shares entered into on November 23, 2025, with a closing expected on November 25, 2025.
Key Financial Metrics
The filing details a capital raise transaction rather than operational financial results. Key metrics include:
- Shares Issued: 3,826,530 ordinary shares.
- Purchase Price: $3.92 per share.
- Total Proceeds: Approximately $15.00 million (calculated as 3,826,530 shares x $3.92).
- Investor Type: Single institutional investor.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions for the period.
Material Changes
The primary material change is the execution of the securities purchase agreement for the registered direct offering. This transaction represents a significant increase in the company's share count and cash resources, subject to customary closing conditions.
Guidance, Outlook, and Risks
Management commentary is limited to the transaction details and standard forward-looking statements. The filing highlights several risks that could cause actual results to differ from expectations:
- Development and Commercialization: Risks regarding the completion of the Nanox System, feasibility demonstrations, and market acceptance of the pay-per-scan business model.
- Regulatory: Uncertainty regarding the timing and receipt of regulatory clearances for the Nanox.ARC and Nanox.CLOUD.
- Acquisitions: Risks related to integrating acquired companies (specifically mentioning VHC IT) and realizing anticipated benefits.
- Geopolitical and Macroeconomic: Specific risks related to the war between Israel and Hamas, as well as global inflation, interest rates, and supply chain costs.
- Operational: Dependence on third-party manufacturers and the ability to manage expenses while maintaining growth.
Investor Verification Checklist
- Confirm the closing of the offering on or around November 25, 2025.
- Verify the actual cash proceeds received after deducting transaction costs and underwriting fees.
- Review the updated share count and potential dilution impact on existing shareholders.
- Monitor regulatory milestones for the Nanox.ARC and Nanox.CLOUD platforms.
- Assess the impact of the ongoing conflict in Israel on the company's operations and supply chain.